Cargando…
The druggable schizophrenia genome: from repurposing opportunities to unexplored drug targets
There have been no new drugs for the treatment of schizophrenia in several decades and treatment resistance represents a major unmet clinical need. The drugs that exist are based on serendipitous clinical observations rather than an evidence-based understanding of disease pathophysiology. In the pre...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956592/ https://www.ncbi.nlm.nih.gov/pubmed/35338153 http://dx.doi.org/10.1038/s41525-022-00290-4 |